XML 209 R91.htm IDEA: XBRL DOCUMENT v3.24.3
SEGMENT REPORTING (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Total assets $ 64,519,982   $ 64,519,982   $ 66,014,811 $ 68,038,621
Total assets         75,724,599  
Segment profit / (loss)         (9,439,727)  
Revenue $ 12,411,048 $ 12,823,797 $ 40,202,238 $ 37,537,003 53,376,874 $ 50,347,652
Wholesale [Member]            
Total assets         28,193,797  
Segment profit / (loss)         (1,661,252)  
Revenue         50,744,468  
Pharma manufacturing [Member]            
Total assets         15,605,459  
Segment profit / (loss)         (1,232,732)  
Revenue         344,708  
Nutraceuticals and Pharmaceuticals [Member]            
Total assets         28,054,242  
Segment profit / (loss)         (3,552,718)  
Revenue         2,287,698  
Other [Member]            
Total assets         3,871,101  
Segment profit / (loss)         (2,993,026)  
Revenue         $ 0